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Large databases can be a rich source of clinical and administrative information on broad populations. These datasets are
characterized by demographic and clinical data for over 1000 patients from multiple institutions. Since they are often
collected and funded for other purposes, their use for secondary analysis increases their utility at relatively low costs.
Advantages of large databases as a source include the very large numbers of available patients and their related medical
information. Disadvantages include lack of detailed clinical information and absence of causal descriptions. Researchers
working with large databases should also be mindful of data structure design and inherent limitations to large databases,
such as treatment bias and systemic sampling errors. Withstanding these limitations, several important studies have been
published in vascular care using large databases. They represent timely, “real-world” analyses of questions that may be too
difficult or costly to address using prospective randomized methods. Large databases will be an increasingly important
analytical resource as we focus on improving national health care efficacy in the setting of limited resources. ( J Vasc Surg
2010;52:768-74.)While prospective randomized-controlled trials are ac-
cepted as the most reliable form of scientific evidence in
clinical medicine,1 trials often cannot be conducted be-
cause of ethical, financial, and practical reasons.2-4 Indeed,
previous literature has demonstrated that results from ran-
domized controlled trials exist to support the main treat-
ment interventions for just 53% of general medicine inpa-
tients5 and only 24% of general surgical and vascular
surgical patients.6 In addition, the effects of new techniques
and devices must often be evaluated with observational
data, often obtained from large registries or databases,7
since 5 to 10 years are typically required from conception of
a clinical trial to dissemination of its results.
Support from randomized trials cannot and should not
be demanded of all treatment interventions used in clinical
practice.4 In many situations, observational studies may
serve an important role in guiding clinical decision-making.
Central to the performing of high-quality observational
studies is the availability of large databases containing data
elements of clinical interest. Such databases have been used
with increasing frequency for clinical research in vascular
surgery and other fields. Herein are discussed many aspects
of large databases relevant to the vascular surgery clinical
research and practice.
LARGE DATABASE DESIGN
Database structure. The data contained in a database
is organized into a database model, which defines the
structure and relationships of the data elements to each
other. Understanding a database’s structure is critical in
querying and analyzing its data. The most common data-
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768base model is the relational model and can be represented
by a table of rows and columns. Attributes, such as “name,”
“age,” and “gender” are listed in columns. Each “name,”
representing a patient, has a corresponding “age” and
“gender,” and the relationships between these elements
define the database. In relational databases, a key serves as
the attribute that defines the grouping of related data
elements. Most often in medical databases, a patient iden-
tifier (eg, patient medical record number) is the key that
defines the name, age, gender, and other data elements
related to each patient.
Hierarchical databases allow for multiplicity of at-
tributes while still preserving ordered relationships (one-to-
many relationships). For example, each patient may have
more than one procedure in their medical history, and
patients may have varying numbers of procedures. How-
ever, each unique procedure only has one associated pa-
tient. Hierarchical databases are represented by tree-like
organizational diagrams that illustrate the relationships be-
tween attributes. Proper query of hierarchical databases still
requires the key (eg, medical record number), but analysis
of the data requires advanced techniques to account for
multiplicity. Network databases allow for even greater flex-
ibility of relationships, by using many-to-many relation-
ships and being represented as a lattice. Issues with multi-
plicity are magnified in working with network databases. In
practice, modern databases may contain characteristics
from more that one structure type, but it is important to
understand the fundamental structure in order to properly
analyze the data.
Privacy protection. The protection of patient and
institutional privacy is an important and necessary safe-
guard measure in all healthcare databases. This is achieved
by assigning database defined identifiers that replace real
identifiers, such as patient name, medical record number,
and institutional name. Despite these measures, coded data
elements with few entries are at theoretical risk of being
reverse-identified through deduction. For example, there
may be only a few patients with a rare disease and additional
demographic information (age, gender, race, zip code) may
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possibility, many databases reclassify these patients into
broader diagnostic categories or exclude them all together.
Researchers who wish to analyze rare diseases or infrequent
occurrences should be aware of this recoding possibility
and request raw or minimally modified data if available.
Diagnostic and procedural coding. Medical data is a
key component of large databases used for outcomes re-
search. In order to provide consistency and comparability
of medical information, most large databases use well-
accepted medical diagnosis coding systems. The Interna-
tional Statistical Classification of Diseases and Health Re-
lated Problems (ICD) classification is published by the
World Health Organization and is designed to promote
international consistency in the collection, classification,
and reporting of morbidity and mortality statistics. ICD
codes classify all diseases as well as a variety of signs,
symptoms, complaints, abnormal findings, social circum-
stances, and external causes of disease or injury. The other
widely used coding system in the US is the Current Proce-
dural Terminology (CPT) codes, owned andmaintained by
the American Medical Association. CPT codes were de-
signed to allow healthcare providers to report inpatient and
outpatient procedures and services rendered to patients and
to provide more details about procedures than ICD proce-
dure codes. Although most large databases use ICD codes
for diagnoses, the use of CPT codes for procedures varies
among databases. Conversion between CPT and ICD pro-
cedural codes is possible but difficult because of differences
in coding specificity.
Longitudinal data. Most large administrative data-
bases are cross-sectional in that they contain information
within a brief time period. Each time period (usually yearly)
is distinct from the next, and no linkage between periods is
available. For example, patients who have repeated proce-
dures may not be correctly identified from one period to
the next because recoding of identifiers for privacy protec-
tion would prevent such linkages. In some cases, even if the
patient received two or more procedures within one year
(but during different hospitalizations), cross-sectional da-
tabases may not adequately record this multiplicity by
design. However, the nature of vascular care relies on
longitudinal analysis of patient outcomes. Some databases,
such as the National Surgical Quality Improvement Pro-
gram (NSQIP; see below) have included longitudinal follow-
up data as an important feature.
STRENGTHS AND LIMITATIONS OF USING
LARGE DATABASES
Sample size and other advantages. Perhaps the most
important advantage of using databases is the large sample
size available for analysis. A large sample size typically
represents a larger proportion of the population of interest,
thereby reducing sampling error and increasing external
validity.8 The inclusion of large numbers of patients from
multiple centers helps to reduce procedure selection biases
as well as differences among groups that might otherwise
reduce the external validity of single center studies. Havinglarge numbers of variables collected on large numbers of
patients also allows for the formation of robust mathematical
models for hypothesis testing. Finally, because of the hetero-
geneity of the population typically captured, effectiveness (the
effect of an intervention in general clinical situations) rather
than efficacy (the effect of a intervention in ideal situations) is
the focus.9 In essence, the analysis of large, population-based
datasets reflects “real world” practice.
As database analyses utilize data that has been already
collected, studies based ondatabases are usually less expensive,
less obtrusive, less likely to be ethically objectionable, and
quicker to perform.Observational studies, where patients and
their courses are observed, andno intervention ismandatedby
the study, may in fact be better for studies that focus on the
disease incidence in a population, disease mortality, volume-
outcome relationships, national trends in the use of proce-
dures, and disparities in healthcare delivery. Many of the
current largemedical databaseswere not created for outcomes
analysis, but rather for financial or administrative purposes,
such as billing and record-keeping. They containmedical data
in so far as to link diagnoses and procedures with charges and
billings. This is helpful in that the collection of data is likely
unbiased. However, data otherwise of interest to clinical re-
searchers (such as left vs right extremity and anatomic descrip-
tions of vascular bypasses)may not be captured, ormay not be
captured accurately, in administrative databases. In general,
the lack of specificmedical detail in large databases is balanced
by the large numbers of patients available for analysis. Aware-
ness of these tradeoffs will help researchers design studies that
capitalize on the uniqueness of data for each database.
Treatment bias. One of the most important limita-
tions of database analyses is bias from treatment assign-
ment. The observed treatments were not randomly as-
signed, but rather the decisions were made based on patient
characteristics, provider preference, and other clinical fac-
tors. This may bemanifest in ways that are obvious (patients
undergoing an open surgical option having higher Trans-
Atlantic Inter-Society Consensus classification or multiple
anatomic levels of disease than patients undergoing an
alternative endovascular intervention) or subtle (a slight
tendency for patients with Medicaid or Medicare to have
treatment in outpatient centers rather than hospitals). Pro-
cedural selection bias is problematic because it confounds
direct comparisons between groups, since the groups may
not be similar in relevant characteristics. Fortunately, sev-
eral study designs are available to reduce bias and improve
the ability to infer causal relationships or relate outcomes
between variables in non-randomized studies. The most
commonly employed method is multivariate analysis,
where various forms of regression models (logistic regres-
sion, linear regression, or Cox proportional hazards mod-
els) are used to estimate the effects of multiple variables on
a given outcome variable. Case-control matching, propen-
sity scoring methods, and instrumental variables are other
methods for reducing baseline differences and achieving an
“apples to apples” comparison.10-12 While powerful in
minimizing treatment bias, such methodologies do not
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sured, unmeasurable, and unidentified variables.
Sampling error and missing data. At the very best,
large databases are incomplete samples of the cohorts they
represent. If sampling occurs randomly, the database can
still serve as a good estimate of the population with an
acceptable sampling error, such as the 20% sampling in the
Nationwide Inpatient Sample. However, if patients or data
elements are missing because of systemic causes, then the
database is susceptible to systemic bias. For example, if data
from patients in urban hospitals is consistently underre-
ported due to lack of database administrative staff, then the
frequency of diseases and procedures that may be associated
with urban hospitals will be underrepresented. Many data-
bases only subsample the population by design because of
cost or logistic concerns. In doing so, database administra-
tors must ensure that the sampling algorithms will result in
a subset of patients representative of the entire population
of interest. Sampling error decreases as sample size in-
creases and approaches the true population size. Special
care must be taken to adequately sample small subgroups,
such as racial minorities, or rare diseases of interest. Their
small numbers make them more susceptible to sampling
error.
Patients and their related data elements may also be
missing from the database due to clerical or logistic reasons.
In addition, missing data may not be randomly distributed
among the database sample but is rather specific to the
patient (ie, different sets of variables collected at different
study sites). Missing data is problematic in that it may
introduce statistical error and bias results. In general, a
variable should be included in a multivariate analysis only if
5% of its values are missing. Methods do exist to replace
missing values, such as using the mean value for a given
variable or using logistic regression formulas to impute a
value, but suchmethods should be limited to cases in which
no more than 5% to 15% of the values of a variable are
missing.13-14
Drawing conclusions about causal relationships.
One of the chief criticisms of observational studies is that
it is more difficult to draw firm causal conclusions be-
cause of the potential for bias and confounding when
compared with randomized controlled trials. As early as
1965, Sir Austin Bradford Hill (the British epidemiolo-
gist and statistician known for initiating the first random-
ized trial in medicine), recognized the importance of
observational studies to clinical medicine and the need to
infer causal relationships from such studies when giving
his presidential address to the Royal Society of Medi-
cine.15 Similar to Koch’s postulates, Hill enumerated
several qualities to help distinguish between causal and
non-causal associations: (1) strength of association
(stronger associations are more likely to be causal in
nature); (2) consistency of the association among stud-
ies; (3) “specificity” of the association (a specific, identi-
fiable factor is associated with a particular effect, and its
absence negates); (4) temporal relationship of the asso-
ciation (the quality thought to be causal consistentlyoccurs before the quality thought to be the effect); (5)
biological gradient (ie, higher doses, exposures, levels,
etc. produce larger effects); (6) the relationship is a
biologically plausible relationship; (7) the association is
“coherent” (not in serious conflict with other previously-
established or well-accepted associations).15 These qual-
ities are important to those drawing conclusions from
database studies, and authors should attempt to address
these points whenever possible.
LARGE DATABASES IN VASCULAR SURGERY
Nationwide Inpatient Sample. The Nationwide In-
patient Sample (NIS) is part of the Healthcare Cost and
Utilization Project (HCUP) and is sponsored by the
Agency forHealthcare Research andQuality (AHRQ).NIS
is the largest all-payer inpatient care, publicly-available da-
tabase in the United States. It represents five to eight
million hospital stays from 1000 hospitals sampled to rep-
resent a 20% stratified sample of US community hospitals.
As such, outcomes calculated from the NIS are felt to be
accurate estimates of national outcomes.16-17 The NIS
definition of “community hospital” is defined by the Amer-
ican Hospital Association to be all non-federal, short-term,
general and specialty hospitals, such as pediatric hospitals,
public hospitals, and academic centers. These hospitals
comprise approximately 90% of inpatient discharges in the
US, whereas the other 10% come from hospitals not in-
cluded in NIS, such as long-term hospitals, psychiatric
hospitals, VA hospitals, and alcohol/drug dependency
treatment facilities. NIS data is available from 1988, al-
though beginning in 1998, data coding and sampling
methods were changed to improve the representativeness
of the data. The most currently available year is 2006,
which contains data from 1045 hospitals from 38 states.18
NIS contains over 100 clinical and non-clinical data
elements for each hospital stay. These elements include
patient demographics (age, gender, race, and median in-
come per zip code), primary and secondary diagnoses,
primary and secondary procedures, admission status (rou-
tine, urgent, or emergent), payer source, and hospital char-
acteristics (public vs private, size, and teaching status). Data
elements most often used as outcome variables include
discharge disposition (in-hospital death vs discharge to
home, health services, or other facilities), hospital charges,
and length of stay. Other outcome endpoints can be cre-
ated from data elements provided, such as the frequency for
postoperative procedures, such as feeding tubes or trache-
ostomy.19 In studies utilizing NIS data, comorbidities are
described using a combination of primary and secondary
diagnoses, HCUP-defined comorbidities,20 or other indi-
ces such as the Charlson/Demayo and Elixhauser methods
of quantifying comorbidities.21-23 Other than the ICD-
9CM procedural codes, the NIS does not provide other
procedural variables such as CPT. Likewise, other than
in-hospital mortality, time-to-event outcomes such as long-
term survival, patency, or limb salvage are not provided,
and the de-identification processes used to protect patient
confidentiality preclude the linkage of NIS data with other
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means to assess long-term outcomes.
The national in-hospital mortality of many vascular
surgical procedures has been based upon data from NIS,
including renal artery bypass grafting20 and endovascular
aneurysm repair (EVAR) for ruptured infrarenal abdominal
aneurysms.19 In addition, the NIS has allowed for study of
the volume-outcome relationship of many vascular surgical
procedures, including open repair of descending thoracic
aortic aneurysm,24 carotid endarterectomy, elective ab-
dominal aortic aneurysms, and lower extremity bypass.25
Observations on national trends of the prevalence of new
procedures such as EVAR for ruptured abdominal aneu-
rysm have also been based on the NIS data.19,26 Finally,
because the NIS is thought to be an accurate representation
of the overall US inpatient population, it represents an ideal
source for studying disparities in access to health care.27
The dataset has also been used to demonstrate the under-
representation of women and ethnic minorities in random-
ized trials of aortic aneurysm repair, carotid revasculariza-
tion, and lower extremity revascularization.28
Because NIS data is based on inpatient encounters,
there is no information about outpatient care. Linkage of
multiple inpatient encounters for the same patient over
time is also not possible. Since many vascular surgery out-
comes of interest are long-term measures of graft patency,
stroke prevention, limb salvage, and survival, the use of NIS
data to answer these questions is quite limited.
Other HCUP-funded databases. Several other
HCUP databases derived from participating HCUP hospi-
tals are publicly available and may be more applicable for
some researchers. The State Inpatient Databases (SID)
contain inpatient discharge data from participating states
and their hospitals. The data is reformatted to facilitate
multi-state comparisons and analyses. In total, SID in-
cludes approximately 80% of all US hospital discharges.
The State Ambulatory Surgery Databases (SASD) contain
outpatient surgical encounters from participating HCUP
hospital-affiliated and freestanding surgical centers, and is
also reformatted to facilitate multi-state comparisons and
analyses. Composition and completeness of the data in SID
and SASD varies from state to state. SASD has been used to
study outpatient procedures in general surgery,29 otolaryn-
gology,30 and gastroenterology.31 The Kid’s Inpatient Da-
tabase (KID) is issued every 3 years and contains inpatient
discharge data for children. Currently, the most recently
available year is 2006 and contains SID data from 38 states
on children up to 20 years old. All HCUP databases are
distributed from the HCUP Central Distributor to re-
searchers who complete a HCUP Data Use Agreement.
National Surgical Quality Improvement Program.
The NSQIP has its origins in the 1980s as the Center for
the Continuous Improvement in Cardiac Surgery at the
Denver Veterans AdministrationMedical Center (VAMC),
which issued semi-annual reports of risk-adjusted morbid-
ity and mortality for VAMC with open-heart surgeries. In
1991, a similar analysis was begun for non-cardiac surgeries
in these 44 VAMC in the form of the National VA SurgicalRisk Study (NVASRS). NSQIPwas established in 1994 and
utilized the methods of data collection, risk adjustment,
and reporting from the NVASRS to apply to all VAMC that
perform major surgery. In 1999, a pilot program was
conducted among non-VAMC hospitals that established
the applicability of NSQIP methodology to the private
hospital sector.32-33 Through the American College of
Surgeons, NSQIP is now available to any qualified private
sector hospital as a tool for reducing surgical morbidity and
mortality, as well as benchmarking to other comparable
hospitals.
ACS NSQIP collects data for 135 variables through
software designed to automatically populate certain vari-
able fields and by using local surgical clinical nurse review-
ers (SCNR) who review medical charts for more complex
variables. The high quality of the data is maintained by
training programs for SCNRs and inter-rater reliability
audits for participating sites. Not all cases are captured in
the database, however. The goal of recording “major cases”
includes cases performed under general, spinal, and epi-
dural anesthesia. Specific procedures such as carotid endar-
terectomy, inguinal herniorrgraphy, parathyroidectomy,
and thyroidectomy, breast lumpectomy, and endovascular
abdominal aortic aneurysm repair are always captured re-
gardless of anesthesia type. The exclusion criteria include
cases where patients are younger than 16 years of age, had
more than three inguinal herniorraphies or breast lumpec-
tomies in an 8-day survey period, and traumas, transplants,
organ donors, and cases occurring concurrent with other
recorded procedures.
Participating institutions receive semiannual reports
comparing their risk-adjusted surgical outcomes with other
participating centers. The results are displayed as a rank-
ordered ratio of observed postoperative events (deaths or
complications) divided by the expected number of events
based on adjustment of preoperative risk factors. Sites with
observed/expected (O/E) ratios significantly less than one
are performing better than expected, and those with O/E
ratios significantly greater than one are performing worse
than expected. The rank-order also allows each institution
to see its relative rank compared with other institutions,
though institutional identity is kept anonymous. Qualified
researchers can request the Participant Use Data File
(PUF), which contains aggregate NSQIP patient-level data
with coded identifiers for patient, provider, and hospital
variables. The 2007 PUF contains over 210,000 cases from
187 institutions.
Some of the vascular surgery topics investigated using
NSQIP data include open and endovascular repair of rup-
tured abdominal aortic aneurysm,34 perioperative variables
associated with morbidity and mortality after infrainguinal
bypass surgery,35 carotid endarterectomy outcomes in high
risk patients,36 and the effects of anesthesia type on graft
failure, pneumonia, and cardiac events after infrainguinal
bypass.37 However, many procedural variables and relevant
outcomes of vascular procedures are not collected by the
current NSQIP system. The Society of Vascular Surgery
and NSQIP are currently working together to broaden the
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Medicare and Medicaid. The Centers for Medicare
and Medicaid Services (CMS) is an agency within the
United States Department of Health and Human Services
that administers the Medicare program and works with
state governments to administer Medicaid and the State
Children’s Health Insurance Program. In support of its
operations, CMS gathers data onMedicare/Medicaid ben-
eficiaries, claims, providers, and clinical data. CMS data is
available in three categories that differ by data privacy
levels. Identifiable Data Files (IDF) contain actual benefi-
ciary and provider information, which allows for better
tracking and specific analyses. Formal and detailed applica-
tion to CMS is required to obtain IDF data. Limited Data
Set Files (LDS) are devoid of data elements that may lead to
identification of beneficiaries. Non-Identifiable Data Files
contain data within the public domain and includes sum-
mary information.
Within each category of data, specific files are available
for analytic use. One of the most commonly used files are
the Standard Analytical Files (SAF), which are organized by
the type of billing claim, including inpatient care, outpa-
tient care, durable medical equipment, physicians, suppli-
ers, home health agencies, hospice care, and skilled nursing
facilities. Another set of often used data are the Medicare
Provide Analysis and Review (MEDPAR) files. MEDPAR
records are based on the patient’s admission to an inpatient
hospital and continue until the patient’s discharge home or
discharge from a skilled nursing facility. This allows research-
ers to track inpatient presentation and treatment outcomes
over time.
State, regional, and societal databases. Hospitalization
and discharge data is collected in most states in the US for
a variety of reasons. Such efforts are typically funded by a
state health agency, and data is usually available to research-
ers. Like the NIS, data collected usually focuses on diagno-
sis (categorized by ICD-9 or Diagnosis Related Group
code), demographics, length of stay, charge data, and dis-
charge disposition. Data specific to vascular procedures or
relevant endpoints are not available. Nevertheless, discharge
databases from many states have been used for published
studies in vascular surgery, including California,38 Florida,39
Maryland,40 and Washington.41 These data appear useful in
investigating trends in volume, the volume-outcome relation-
ship, and clinical outcomes. It should be noted, however, that
endpoints for clinical outcomes are limited to in-hospital
mortality, readmission, and length of stay. While such end-
points may be useful for procedures such as open repair of
abdominal aortic aneurysm, theymay not be sensitive enough
to compare outcomes for procedures associated with short
stay, low mortality such as carotid endarterectomy, carotid
artery stenting, elective lower extremity angioplasty, or dialysis
access procedures.
Vascular surgery centers in Maine, New Hampshire,
Vermont, and Massachusetts have shared outcomes data to
form the Vascular Study Group of Northern New England
(VSGNNE) in an attempt to reduce complications andimprove processes of care. The VSGNNE is currently com-
prised of data from more than 50 surgeons at 11 centers
and is partially funded by the Centers for Medicare and
Medicaid Services. Data is collected on five vascular surgical
procedures: carotid endarterectomy, carotid artery stent-
ing, open and endovascular abdominal aortic aneurysm
repairs, and lower extremity bypass. Data collected includes
variables describing previous relevant procedures, proce-
dural details, and postoperative complications.42 The use of
such procedure-specific data-entry forms allows for the
collection of detailed information (such as precise anatomic
location of inflow and outflow in lower extremity bypass)
not typically available in many large databases. Thus far,
published findings of studies based on the VSGNNE data
have focused on predicting outcomes of lower extremity
bypass43 and the occurrence of postprocedural hypoten-
sion following carotid artery stenting or carotid endar-
terectomy.44 The data are available only to members of
VSGNNE at this time.
Several medical societies have also begun their own
large databases to collect outcomes data for research and
quality improvement. The CMS requirement for collection
and analysis of institutional carotid stenting data has facili-
tated the creation of several databases, including the Soci-
ety of Vascular Surgery’s Vascular Registry45 and the Amer-
ican College of Cardiology’s Carotid Artery Revascularization
and Endarterectomy (CARE) Registry. Advantages of so-
cietal registries include large patient numbers, availability of
disease-specific clinical data, and generalizability of the
findings based on broad and diverse institutional participa-
tion in the registries.
Secondary analyses from multi-center trials and
longitudinal epidemiological studies. Randomized tri-
als are designed to test one main hypothesis and typically
several other secondary (and often related) hypotheses. To
ensure that groups of patients are comparable and to min-
imize the effects of bias, the collection of baseline and study
endpoint data is often exhaustive. Thus, datasets from
large, multicenter clinical trials often describe well-defined
patient populations and contain clinical variables not
present in administrative databases. For example, The
Project of Ex Vivo Vein Graft Engineering via Transfection
III (PREVENT III) was a multicenter randomized trial
that investigated the effect of edifoligide on the patency of
vein grafts in infrainguinal bypass. More than 1400 patients
were enrolled among 83 centers in the United States and
Canada.46 While edifoligide was found to have no signifi-
cant effect on patency rates, the database has served as a rich
source of information for studies of lower extremity bypass
(as it is the largest critical limb ischemia database to date).
Indeed, the rigorous data collection has provided accurate
estimates of wound complications among patients under-
going lower extremity bypass47 and technical and vein graft
factors associated with patency.48 In addition, the PREVENT
III data has been used to examine the influence of critical
limb ischemia, comorbidities, and postoperative events on
resource utilization and length of stay,49 as well as dispari-
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ated with ethnicity, race, and gender.50
Longitudinal studies have also provided important data
for understanding risk factors, epidemiology, and natural
history of vascular disease. The modern prototype of such
logitudinal studies is the Framingham Heart Study, an
ongoing epidemiological study that has followed a cohort
of more than 5000 men and women since 1948. Secondary
analyses of these studies have demonstrated associations
between comorbidities such as diabetes, cigarette smoking,
hypertension, hypercholesterolemia, and advanced age and
the development of intermittent claudication51 and
stroke.52 Similar large cohorts from Mälmo, Sweden53-54
and Rotterdam, the Netherlands55 have also been used as
sources of epidemiological data on vascular disease. While
designed for other (non-vascular) primary objectives, such
databases may provide invaluable insights into the natural
history of vascular diseases, and their use may only be
limited by the creativity of investigators.
CONCLUSIONS
Observational data from databases have provided and
will continue to provide important findings in the field of
vascular surgery. Important findings regarding the inci-
dence or prevalence of vascular disease in a population,
disease mortality, volume-outcome relationships, national
trends, disparities in healthcare delivery, and other impor-
tant insights will continue to be reported through studies
utilizing large databases.
While large database analysis does have advantages,
including generalizability, lower costs, and negligible risks
to patients with appropriate privacy protection, limitations
also exist. Perhaps the most important limitation, the po-
tential for bias and confounding, can be minimized by
statistical methodology such as multivariate analyses, but
cannot be eliminated. For this reason, important findings of
large database analyses should be corroborated by analyses
of other, independent databases or by prospective random-
ized clinical trials. Nevertheless, large databases will con-
tinue to be an important resource to address important
issues in vascular surgery and healthcare as a system.
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